Honokiol ameliorated glucose metabolism disorder by increasing glucose consumption, insulin-stimulated 2-NBDG uptake, and translocation of GLUT2 and alleviated oxidative stress by reducing ROS accumulation and loss of mitochondrial membrane potential in glucosamine-induced HepG2 cells. This evidence concerns the gene SLC2A2 and glucose metabolism disease.